Levosimendan, an investigational treatment for pulmonary hypertension and heart failure with preserved ejection fraction, or PH-HFpEF — which showed positive...
In late July, the U.S. Food and Drug Administration (FDA) approved a new formulation of Janssen‘s Uptravi (selexipag) for use...
When I was younger, my life with pulmonary hypertension (PH) was busy. I was active in dance, softball, and the...
A peptide — a short chain of amino acids, the building blocks of proteins — called BPC 157 may prevent...
Registration is now open for the 2021 Rare Diseases and Orphan Products Breakthrough Summit, which will be held virtually Oct....
Note: This story was updated Aug. 11, 2021, to clarify that the researchers are not affiliated with the Virginia Tech...
Certain chemokines — signaling molecules that attract white blood cells to sites of infection — may be blood markers of...
More than 600 people participated in the 10th annual Rare Disease Week on Capitol Hill 2021, held virtually July 14–22,...
Do you struggle to create boundaries to protect your health? Do others say that you are using your chronic illness...
Pulnovo Medical recently raised an undisclosed amount totaling millions of dollars in investment funding to support clinical trials and product...
“The surgery went well, with no complications, and the new heart and lungs are functioning beautifully.” Aug. 7 marks the...
The U.S. Food and Drug Administration (FDA) has approved an intravenous form of Uptravi (selexipag) — one infused directly into...